Abstract: The Coma Recovery Scale-Revised (CRS-R) is a clinical behavioral method for assessing the levels of consciousness and perceptual abilities in patients with Disorders of Consciousness (DOC).
EQS-News: AL-S Pharma AG / Key word (s): Study results Additional Phase 2 Data of AL-S Pharma's Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification ...
ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
The lesson that Tehran will take away from this conflict is that it needs an ironclad deterrent in the form of a nuclear weapon. The primary objective of the war now unfolding following the attack by ...
Andre Berto On Using His Uppercut On Shawn Porter Forced to Demonstrate on Bystander. please SUPPORT!!! SUBSCRIBE, share & like Please check out our facebook page and hit the like button. google plus ...
When veterinarians told Sydney tech entrepreneur Paul Conyngham that his rescue dog Rosie had months to live, he didn't accept the prognosis. Instead, the data scientist and machine learning engineer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results